114 related articles for article (PubMed ID: 8221778)
1. Cardiovascular effects of neuropeptide Y: receptor interactions and cellular mechanisms.
McDermott BJ; Millar BC; Piper HM
Cardiovasc Res; 1993 Jun; 27(6):893-905. PubMed ID: 8221778
[No Abstract] [Full Text] [Related]
2. An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization.
Dumont Y; Quirion R
EXS; 2006; (95):7-33. PubMed ID: 16382995
[No Abstract] [Full Text] [Related]
3. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues.
Dumont Y; Martel JC; Fournier A; St-Pierre S; Quirion R
Prog Neurobiol; 1992; 38(2):125-67. PubMed ID: 1312243
[No Abstract] [Full Text] [Related]
4. Characterization of the binding site of neuropeptide Y to the rabbit kidney receptor using multiple peptide synthesis.
Beck-Sickinger AG; Dürr H; Hoffmann E; Gaida W; Jung G
Biochem Soc Trans; 1992 Nov; 20(4):847-50. PubMed ID: 1487078
[No Abstract] [Full Text] [Related]
5. Neuropeptide Y and its receptor antagonists. Use of an analog mixture-screening strategy.
Tatemoto K
Ann N Y Acad Sci; 1990; 611():1-6. PubMed ID: 2174216
[No Abstract] [Full Text] [Related]
6. Structure-activity relationships of neuropeptide Y analogues with respect to Y1 and Y2 receptors.
Beck-Sickinger AG; Jung G
Biopolymers; 1995; 37(2):123-42. PubMed ID: 7893945
[TBL] [Abstract][Full Text] [Related]
7. [Neuropeptide Y].
Mori Y
Nihon Rinsho; 2000 Jan; 58 Suppl 1():85-9. PubMed ID: 11026241
[No Abstract] [Full Text] [Related]
8. High-affinity analogues of neuropeptide Y containing conformationally restricted non-proteinogenic amino acids.
Beck-Sickinger AG; Hoffmann E; Paulini K; Reissig HU; Willim KD; Wieland HA; Jung G
Biochem Soc Trans; 1994 Feb; 22(1):145-9. PubMed ID: 8206212
[No Abstract] [Full Text] [Related]
9. Biophysical methods to study ligand-receptor interactions of neuropeptide Y.
Bettio A; Beck-Sickinger AG
Biopolymers; 2001; 60(6):420-37. PubMed ID: 12209475
[TBL] [Abstract][Full Text] [Related]
10. Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy.
Michel MC; Gaida W; Beck-Sickinger AG; Wieland HA; Doods H; Dürr H; Jung G; Schnorrenberg G
Mol Pharmacol; 1992 Oct; 42(4):642-8. PubMed ID: 1331755
[TBL] [Abstract][Full Text] [Related]
11. Effects of covalent dimerization on the structure and function of the carboxy-terminal fragment of neuropeptide Y.
Uegaki K; Murase S; Nemoto N; Kobayashi Y; Yoshikawa S; Yumoto N
Biochem Biophys Res Commun; 1997 Dec; 241(3):737-43. PubMed ID: 9434778
[TBL] [Abstract][Full Text] [Related]
12. NPY and NPY receptors: presence, distribution and roles in the regulation of the endocardial endothelium and cardiac function.
Jacques D; Sader S; Perreault C; Abdel-Samad D
EXS; 2006; (95):77-87. PubMed ID: 16382998
[No Abstract] [Full Text] [Related]
13. [Neuropeptide Y: psychopharmacological and clinical aspects].
Nakagawara M; Sato Y
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):117-27. PubMed ID: 7941776
[TBL] [Abstract][Full Text] [Related]
14. Recent developments with neuropeptide Y receptor antagonists.
Lundberg JM; Modin A; Malmström RE
Trends Pharmacol Sci; 1996 Sep; 17(9):301-4. PubMed ID: 8885691
[No Abstract] [Full Text] [Related]
15. Neuropeptide Y and central cardiovascular regulation. Focus on its role as a cotransmitter in cardiovascular adrenergic neurons.
Fuxe K; Aguirre JA; Agnati LF; von Euler G; Hedlund P; Coveñas R; Zoli M; Bjelke B; Eneroth P
Ann N Y Acad Sci; 1990; 611():111-32. PubMed ID: 1978995
[No Abstract] [Full Text] [Related]
16. [Neuropeptide Y in the cardiovascular regulation].
Zanin L; Rossi GP; Bernardi S; Pessina AC
Cardiologia; 1990 Mar; 35(3):199-201. PubMed ID: 2245420
[No Abstract] [Full Text] [Related]
17. Galanin-neuropeptide Y (NPY) interactions in central cardiovascular control: involvement of the NPY Y receptor subtype.
Díaz-Cabiale Z; Parrado C; Rivera A; de la Calle A; Agnati L; Fuxe K; Narváez JA
Eur J Neurosci; 2006 Jul; 24(2):499-508. PubMed ID: 16903855
[TBL] [Abstract][Full Text] [Related]
18. Towards understanding the free and receptor bound conformation of neuropeptide Y by fluorescence resonance energy transfer studies.
Haack M; Beck-Sickinger AG
Chem Biol Drug Des; 2009 Jun; 73(6):573-83. PubMed ID: 19635049
[TBL] [Abstract][Full Text] [Related]
19. Structure of prejunctional receptor binding analog of human neuropeptide Y dimer ANA-NPY.
Barden JA
Biochem Biophys Res Commun; 1995 Oct; 215(1):264-71. PubMed ID: 7575600
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?
Wahlestedt C; Reis DJ
Annu Rev Pharmacol Toxicol; 1993; 33():309-52. PubMed ID: 8494343
[No Abstract] [Full Text] [Related]
[Next] [New Search]
